Hostname: page-component-848d4c4894-nr4z6 Total loading time: 0 Render date: 2024-05-01T02:39:15.237Z Has data issue: false hasContentIssue false
  • English
  • Français

Authors' reply

Published online by Cambridge University Press:  13 June 2014

I Jalenques  and
A-J Coudert
I Jalenques
Affiliation:
Service depsychiatrie de l'adulte etpsycholigie medicale, Centre Hospitalier Universitaire, BP 69, 63003 Clermont -FD, Cedex 1, France
A-J Coudert
Affiliation:
Service depsychiatrie de l'adulte etpsycholigie medicale, Centre Hospitalier Universitaire, BP 69, 63003 Clermont -FD, Cedex 1, France
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Irish Journal of Psychological Medicine , Volume 12 , Issue 1 , March 1995 , pp. 39
Copyright
Copyright © Cambridge University Press 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Alvir, JM, Lieberman, JA. A revaluation of the clinical characteristics of Clozapine-induced agranulocytosis in light of the United States experience. J Clin Psychopharmacol 1994; 14, lex 2501:87–9.Google Scholar
2.Meltzer, HY, Cola, P, Way, L, Thompson, PA, Bastani, B, Davies, MA, Snitz, B. Cost effectiveness of Clozapine in neuroleptic-resistant schizophrenia. Am J Psychiatry 1993; 150;11:1630–83.Google ScholarPubMed
3.Murdock, PS , Williamson, J. A danger in making the diagnosis of Parkinson's disease. Lancet 1982; 2:1212–3.CrossRefGoogle Scholar
4.Cassano, GB, Castrogiovanni, P, Conti, L. Sulpiride versus haloperidol in schizophrenia: a double-blind comparative trial. CurrTherRes 1975; 17: 189–201.Google ScholarPubMed
5.Gerlach, J, Behnke, K, Heltberg, J, et al.Sulpride and haloperidol in schizophrenia: a double-blind cross-over study of therapeutic effect, side effects and plasma concentrations. Br J Psychiatry 1985; 147: 283–8.CrossRefGoogle Scholar
6.Friefman, JH. The management of the levodopa psychoses. Clin Neuropharmacol 1991;14:283–95.CrossRefGoogle Scholar
7.Alberts, JL, Francois, F, Josserand, F. Study of side effects reported in patients under dogmatil (in french). Sem Hop 1985; 61: 1351–7.Google Scholar